{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:44:16Z","timestamp":1787165056958,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.prp.2023.154556","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:45:17Z","timestamp":1684464317000},"page":"154556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The dysfunction of natural killer cells is essential for the development of type 1 diabetes"],"prefix":"10.1016","volume":"247","author":[{"given":"Shahnaz","family":"Sabetkam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Kalarestaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Mazloumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Dizaji Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-2906","authenticated-orcid":false,"given":"Ali","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/mp.56.1.1","article-title":"Molecular aspects of type 1 diabetes","volume":"56","author":"Kelly","year":"2003","journal-title":"Mol. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154556_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","article-title":"Insulin-dependent diabetes mellitus","volume":"85","author":"Tisch","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154556_bib3","series-title":"Mortality and renal disease in type 1 diabetes mellitus\u2014progress made, more to be done","first-page":"3757","author":"Maahs","year":"2006"},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.diabres.2013.11.012","article-title":"Diabetes in the Western Pacific Region\u2014past, present and future","volume":"103","author":"Chan","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib5","article-title":"Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus","volume":"2019","author":"Watanabe","year":"2019","journal-title":"Endocrinol., Diabetes Metab. Case Rep."},{"key":"10.1016\/j.prp.2023.154556_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101563","article-title":"Relationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes","volume":"34","author":"De Mara\u00f1on","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.prp.2023.154556_bib7","first-page":"2020","article-title":"Two to tango: dialogue between adaptive and innate immunity in type 1 diabetes","author":"Sun","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154556_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/microorganisms8070989","article-title":"Enteroviral pathogenesis of type 1 diabetes: the role of natural killer cells","volume":"8","author":"Nekoua","year":"2020","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.prp.2023.154556_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-018-1077-2","article-title":"Enteroviral infections as a trigger for type 1 diabetes","volume":"18","author":"Rodriguez-Calvo","year":"2018","journal-title":"Curr. Diabetes Rep."},{"issue":"11","key":"10.1016\/j.prp.2023.154556_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-016-0806-7","article-title":"The expanding role of natural killer cells in type 1 diabetes and immunotherapy","volume":"16","author":"Fraker","year":"2016","journal-title":"Curr. Diabetes Rep."},{"issue":"19","key":"10.1016\/j.prp.2023.154556_bib11","first-page":"3853","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"11","key":"10.1016\/j.prp.2023.154556_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"6669","key":"10.1016\/j.prp.2023.154556_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.178.2.597","article-title":"P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities","volume":"178","author":"Moretta","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2023.154556_bib15","article-title":"The role of KIR positive NK cells in diseases and its importance in clinical intervention","volume":"92","author":"Asl","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"21","key":"10.1016\/j.prp.2023.154556_bib16","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1073\/pnas.0402065101","article-title":"Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity","volume":"101","author":"Poirot","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154556_bib17","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4049\/jimmunol.0804358","article-title":"Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice","volume":"184","author":"Brauner","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.prp.2023.154556_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.1103474","article-title":"NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza a infection by IFN-\u03b3 and perforin-dependent mechanisms","volume":"189","author":"Ge","year":"2012","journal-title":"J. Immunol."},{"issue":"9626","key":"10.1016\/j.prp.2023.154556_bib19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","article-title":"Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study","volume":"371","author":"Harjutsalo","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prp.2023.154556_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2796.2007.01896.x","article-title":"Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983\u20132002","volume":"263","author":"\u00d6stman","year":"2008","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-006-0456-4","article-title":"Seasonality of birth in children and young adults (0\u201329 years) with type 1 diabetes in Ukraine","volume":"50","author":"Vaiserman","year":"2007","journal-title":"Diabetologia"},{"issue":"Supplement 1","key":"10.1016\/j.prp.2023.154556_bib22","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142018","volume":"41","author":"Association AD","year":"2018","journal-title":"Diabetes care"},{"key":"10.1016\/j.prp.2023.154556_bib23","series-title":"Seminars in immunopathology","article-title":"Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology","year":"2011"},{"issue":"3","key":"10.1016\/j.prp.2023.154556_bib24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/ijms19030794","article-title":"Type 1 diabetes and its multi-factorial pathogenesis: the putative role of NK cells","volume":"19","author":"Marca","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154556_bib25","first-page":"26","article-title":"The mobilisation of early mature CD56 dim CD16 bright NK cells is blunted following a single bout of vigorous intensity exercise in Type 1 Diabetes","author":"Curran","year":"2020","journal-title":"Exerc. Immunol. Rev."},{"key":"10.1016\/j.prp.2023.154556_bib26","article-title":"NK cells in autoimmune diseases: protective or pathogenic?","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2023.154556_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s000110050331","article-title":"Interleukin-15 and its role in chronic inflammatory diseases","volume":"47","author":"Kirman","year":"1998","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib28","first-page":"5","article-title":"Human natural killer cells: a comprehensive review","volume":"27","author":"Sinkovics","year":"2005","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/db06-0493","article-title":"Altered natural killer cells in type 1 diabetic patients","volume":"56","author":"Rodacki","year":"2007","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.prp.2023.154556_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2337\/db09-1706","article-title":"Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling","volume":"60","author":"Qin","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.prp.2023.154556_bib31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1172\/JCI112390","article-title":"Spontaneous diabetes mellitus in the Bio-Breeding\/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells","volume":"77","author":"MacKay","year":"1986","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.prp.2023.154556_bib32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diab.39.7.836","article-title":"Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro","volume":"39","author":"Akamura","year":"1990","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.prp.2023.154556_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF00903343","article-title":"Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes","volume":"29","author":"Negishi","year":"1986","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.prp.2023.154556_bib34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.immuni.2009.08.023","article-title":"How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets","volume":"31","author":"Feuerer","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.prp.2023.154556_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036011","article-title":"NK cells are not required for spontaneous autoimmune diabetes in NOD mice","volume":"7","author":"Beilke","year":"2012","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.prp.2023.154556_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0896-8411(91)90167-B","article-title":"Islet cells but not thyrocytes are susceptible to lysis by NK cells","volume":"4","author":"Kitagawa","year":"1991","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.prp.2023.154556_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2012.08.001","article-title":"NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes","volume":"40","author":"Van Belle","year":"2013","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ni.1834","article-title":"The activating receptor NKp46 is essential for the development of type 1 diabetes","volume":"11","author":"Gur","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.prp.2023.154556_bib39","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.4049\/jimmunol.1101269","article-title":"Recognition and killing of human and murine pancreatic \u03b2 cells by the NK receptor NKp46","volume":"187","author":"Gur","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","article-title":"KIR and disease: a model system or system of models?","volume":"214","author":"Khakoo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.prp.2023.154556_bib41","series-title":"Seminars in immunology","article-title":"The Yin and Yang of HLA and KIR in human disease","year":"2008"},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1744-313X.2007.00739.x","article-title":"Killer cell immunoglobulin\u2010like receptors on NK cells: the how, where and why","volume":"35","author":"Gardiner","year":"2008","journal-title":"Int. J. Immunogenet."},{"issue":"5","key":"10.1016\/j.prp.2023.154556_bib43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.coi.2004.07.013","article-title":"Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation","volume":"16","author":"Dupont","year":"2004","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2023.154556_bib44","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1007\/s00125-011-2299-x","article-title":"An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes","volume":"54","author":"Mehers","year":"2011","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.prp.2023.154556_bib45","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2337\/diabetes.52.10.2639","article-title":"KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects","volume":"52","author":"van der Slik","year":"2003","journal-title":"Diabetes"},{"issue":"2\u20134","key":"10.1016\/j.prp.2023.154556_bib46","first-page":"101","article-title":"NK cells and type 1 diabetes","volume":"13","author":"Rodacki","year":"2006","journal-title":"Clin. Dev. Immunol."},{"issue":"52","key":"10.1016\/j.prp.2023.154556_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009439","article-title":"Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: A PRISMA-compliant meta-analysis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2023.154556_bib48","first-page":"1","article-title":"Association of KIR gene polymorphisms with Type 1 Diabetes: a meta-analysis","author":"Soltani","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1\u20132","key":"10.1016\/j.prp.2023.154556_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.humimm.2006.02.036","article-title":"Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus","volume":"67","author":"Santin","year":"2006","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1196\/annals.1337.027","article-title":"Killer cell immunoglobulin\u2010like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls","volume":"1037","author":"NIKITINA\u2010ZAKE","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154556_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1744-313X.2008.00804.x","article-title":"Combination of KIR 2DL2 and HLA\u2010C1 (Asn80) confers susceptibility to type 1 diabetes in Latvians","volume":"35","author":"Shastry","year":"2008","journal-title":"Int. J. Immunogenet."},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1196\/annals.1375.037","article-title":"Predominance of the group A killer Ig\u2010like receptor haplotypes in Korean patients with T1D","volume":"1079","author":"Park","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.prp.2023.154556_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.humimm.2006.08.295","article-title":"Investigation of KIR gene frequencies in type 1 diabetes mellitus","volume":"67","author":"Middleton","year":"2006","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.prp.2023.154556_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2370.2002.00313.x","article-title":"Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters","volume":"29","author":"Moodie","year":"2002","journal-title":"Eur. J. Immunogenet."},{"issue":"6","key":"10.1016\/j.prp.2023.154556_bib55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1399-0039.2007.00956.x","article-title":"Killer cell immunoglobulin\u2010like receptor genotypes in Japanese patients with type 1 diabetes","volume":"70","author":"Mogami","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.prp.2023.154556_bib56","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s001250100021","article-title":"A choice of death\u2013the signal-transduction of immune-mediated beta-cell apoptosis","volume":"44","author":"Eizirik","year":"2001","journal-title":"Diabetologia"},{"issue":"7083","key":"10.1016\/j.prp.2023.154556_bib57","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-\u03b1\/\u03b2 to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. The","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154556_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1399-0039.2003.00136.x","article-title":"Association of a putative regulatory polymorphism in the PD\u20101 gene with susceptibility to type 1 diabetes","volume":"62","author":"Nielsen","year":"2003","journal-title":"Tissue Antigens"},{"issue":"14","key":"10.1016\/j.prp.2023.154556_bib60","doi-asserted-by":"crossref","first-page":"R713","DOI":"10.1016\/j.cub.2017.05.064","article-title":"Animal communication: when i\u2019m calling you, will you answer too?","volume":"27","author":"Vickers","year":"2017","journal-title":"Curr. Biol."},{"issue":"8","key":"10.1016\/j.prp.2023.154556_bib61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humimm.2015.06.017","article-title":"Association between KIR gene polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis","volume":"76","author":"Li","year":"2015","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.prp.2023.154556_bib62","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/dmrr.1264","article-title":"Killer cell immunoglobulin\u2010like receptor along with HLA\u2010C ligand genes are associated with type 1 diabetes in Chinese Han population","volume":"27","author":"Zhi","year":"2011","journal-title":"Diabetes\/Metab. Res. Rev."},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4049\/jimmunol.172.2.937","article-title":"Regulation of autoimmune diabetes by complete Freund\u2019s adjuvant is mediated by NK cells","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib64","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s40200-020-00569-2","article-title":"Association of KIR gene polymorphisms with type 1 diabetes: a meta-analysis","volume":"19","author":"Soltani","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"5","key":"10.1016\/j.prp.2023.154556_bib65","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.188.5.953","article-title":"Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity","volume":"188","author":"Pessino","year":"1998","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib66","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood-2003-05-1716","article-title":"The mechanisms controlling the recognition of tumor-and virus-infected cells by NKp46","volume":"103","author":"Arnon","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118936","article-title":"Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes","volume":"10","author":"Yossef","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154556_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7150\/jca.5519","article-title":"Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues","volume":"4","author":"Jewett","year":"2013","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2023.154556_bib69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1051\/medsci\/2013294012","article-title":"Les cellules natural killer","volume":"29","author":"Narni-Mancinelli","year":"2013","journal-title":"Med Sci. (Paris)"},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib70","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/eji.201847611","article-title":"Human anti\u2010NKp46 antibody for studies of NKp46\u2013dependent NK cell function and its applications for type 1 diabetes and cancer research","volume":"49","author":"Berhani","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2023.154556_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/77793","article-title":"Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages","volume":"1","author":"Diefenbach","year":"2000","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.prp.2023.154556_bib72","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.immuni.2004.05.008","article-title":"NKG2D blockade prevents autoimmune diabetes in NOD mice","volume":"20","author":"Ogasawara","year":"2004","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.prp.2023.154556_bib73","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.20021973","article-title":"NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules","volume":"197","author":"Lodoen","year":"2003","journal-title":"J. Exp. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382300256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382300256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:59:34Z","timestamp":1759733974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382300256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":73,"alternative-id":["S034403382300256X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154556","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dysfunction of natural killer cells is essential for the development of type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154556"}}